INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Tirzepatide Cuts BMI in Adolescents With Obesity in Phase III Trial

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- NATIONAL HARBOR, Md. -- Tirzepatide (Zepbound) yielded substantial reductions in BMI among adolescents with obesity or overweight with obesity-related complications, the phase III SURMOUNT-ADOLESCENTS trial showed. At week...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    Tirzepatide Cuts BMI in Adolescents With Obesity in Phase III Trial

    (MedPage Today) -- NATIONAL HARBOR, Md. -- Tirzepatide (Zepbound) yielded substantial reductions in BMI among adolescents with obesity or overweight with obesity-related complications, the phase III SURMOUNT-ADOLESCENTS trial showed. At week...

Comments

Comments need JavaScript.